DK1431391T3 - RANTES-mutanter og terapeutiske anvendelser heraf - Google Patents
RANTES-mutanter og terapeutiske anvendelser herafInfo
- Publication number
- DK1431391T3 DK1431391T3 DK03027936T DK03027936T DK1431391T3 DK 1431391 T3 DK1431391 T3 DK 1431391T3 DK 03027936 T DK03027936 T DK 03027936T DK 03027936 T DK03027936 T DK 03027936T DK 1431391 T3 DK1431391 T3 DK 1431391T3
- Authority
- DK
- Denmark
- Prior art keywords
- rantes
- therapeutic uses
- rantes mutants
- mutants
- wild
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- AIDS & HIV (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI972865 IT1297015B1 (it) | 1997-12-23 | 1997-12-23 | Mutanti di rantes e loro applicazioni terapeutiche |
IT98MI001866 IT1302012B1 (it) | 1998-08-07 | 1998-08-07 | Derivati di rantes e loro applicazioni terapeutiche. |
EP98966650A EP1040191B1 (en) | 1997-12-23 | 1998-12-21 | Rantes mutants and therapeutic applications thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1431391T3 true DK1431391T3 (da) | 2005-12-19 |
Family
ID=26331556
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98966650T DK1040191T3 (da) | 1997-12-23 | 1998-12-21 | RANTES-mutanter og terapeutiske anvendelser heraf |
DK03027936T DK1431391T3 (da) | 1997-12-23 | 1998-12-21 | RANTES-mutanter og terapeutiske anvendelser heraf |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98966650T DK1040191T3 (da) | 1997-12-23 | 1998-12-21 | RANTES-mutanter og terapeutiske anvendelser heraf |
Country Status (10)
Country | Link |
---|---|
US (2) | US6608177B1 (da) |
EP (2) | EP1431391B1 (da) |
JP (1) | JP4323094B2 (da) |
AT (2) | ATE308617T1 (da) |
AU (1) | AU2415599A (da) |
CA (1) | CA2316447C (da) |
DE (2) | DE69832216T2 (da) |
DK (2) | DK1040191T3 (da) |
ES (2) | ES2247475T3 (da) |
WO (1) | WO1999033989A2 (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6743594B1 (en) | 1995-06-06 | 2004-06-01 | Human Genome Sciences, Inc. | Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5) |
US6025154A (en) | 1995-06-06 | 2000-02-15 | Human Genome Sciences, Inc. | Polynucleotides encoding human G-protein chemokine receptor HDGNR10 |
UA77950C2 (en) * | 2000-10-04 | 2007-02-15 | Applied Research Systems | Use of mutants of cc chemokines for treatment of multiple sclerosis |
IL162600A0 (en) | 2001-12-17 | 2005-11-20 | Applied Research Systems | Cc-chemokine mutants as cc-chemokine antagonists |
PT1494703E (pt) * | 2002-04-04 | 2006-05-31 | Applied Research Systems | Quimiocinas mutantes que apresentam uma disponibilidade biologica oral melhorada |
US7981410B2 (en) * | 2006-11-13 | 2011-07-19 | Functional Genetics, Inc. | Therapeutic targeting of escort proteins |
MX2010001307A (es) | 2007-08-02 | 2010-07-30 | Novimmune Sa | Anticuerpos anti-proteína regulada con la activación, expresada y secretada por los linfocitos t normales y metodos de uso de los mismos. |
CA3101052A1 (en) | 2018-05-28 | 2019-12-05 | ORION Biotechnology Switzerland Sarl | Methods of inhibiting cerebral inflammation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9703889A (es) * | 1994-12-08 | 1997-08-30 | Glaxo Group Ltd | Peptido rantes y fragmentos y composiciones que lo contienen, para el tratamiento de la inflamacion. |
FR2748938B1 (fr) * | 1996-05-22 | 1998-07-31 | Pasteur Institut | Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih |
AU4561497A (en) * | 1996-09-25 | 1998-04-17 | British Biotech Pharmaceuticals Limited | Human rantes mutants incapable of aggregate formation |
-
1998
- 1998-12-21 JP JP2000526645A patent/JP4323094B2/ja not_active Expired - Fee Related
- 1998-12-21 DE DE69832216T patent/DE69832216T2/de not_active Expired - Lifetime
- 1998-12-21 WO PCT/EP1998/008354 patent/WO1999033989A2/en active IP Right Grant
- 1998-12-21 CA CA002316447A patent/CA2316447C/en not_active Expired - Fee Related
- 1998-12-21 ES ES03027936T patent/ES2247475T3/es not_active Expired - Lifetime
- 1998-12-21 DK DK98966650T patent/DK1040191T3/da active
- 1998-12-21 AT AT03027936T patent/ATE308617T1/de active
- 1998-12-21 AT AT98966650T patent/ATE308616T1/de active
- 1998-12-21 EP EP03027936A patent/EP1431391B1/en not_active Expired - Lifetime
- 1998-12-21 EP EP98966650A patent/EP1040191B1/en not_active Expired - Lifetime
- 1998-12-21 DE DE69832197T patent/DE69832197T2/de not_active Expired - Lifetime
- 1998-12-21 ES ES98966650T patent/ES2247738T3/es not_active Expired - Lifetime
- 1998-12-21 AU AU24155/99A patent/AU2415599A/en not_active Abandoned
- 1998-12-21 DK DK03027936T patent/DK1431391T3/da active
-
1999
- 1999-07-08 US US09/581,070 patent/US6608177B1/en not_active Expired - Fee Related
-
2003
- 2003-03-28 US US10/400,487 patent/US7164000B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69832197T2 (de) | 2006-05-24 |
ATE308616T1 (de) | 2005-11-15 |
US20030216549A1 (en) | 2003-11-20 |
DK1040191T3 (da) | 2005-12-19 |
EP1040191B1 (en) | 2005-11-02 |
EP1431391B1 (en) | 2005-11-02 |
WO1999033989A3 (en) | 1999-08-26 |
JP2002507388A (ja) | 2002-03-12 |
ATE308617T1 (de) | 2005-11-15 |
WO1999033989A2 (en) | 1999-07-08 |
DE69832216D1 (de) | 2005-12-08 |
DE69832197D1 (de) | 2005-12-08 |
EP1431391A3 (en) | 2004-10-06 |
JP4323094B2 (ja) | 2009-09-02 |
ES2247475T3 (es) | 2006-03-01 |
US7164000B2 (en) | 2007-01-16 |
CA2316447A1 (en) | 1999-07-08 |
DE69832216T2 (de) | 2006-05-24 |
EP1040191A2 (en) | 2000-10-04 |
AU2415599A (en) | 1999-07-19 |
EP1431391A2 (en) | 2004-06-23 |
CA2316447C (en) | 2009-07-28 |
ES2247738T3 (es) | 2006-03-01 |
US6608177B1 (en) | 2003-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE185602T1 (de) | Verändertes menschliches il-6 | |
DE69731373D1 (de) | Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen | |
DE69431060D1 (de) | Klonierte glutaminsäure-decarboxylase | |
DE69730038D1 (de) | Lösliche monovalente und multivalente mhc klasse ii fusionsproteine und deren verwendungen | |
DK0960127T3 (da) | Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf | |
ATE218616T1 (de) | Humanes zirkulierendes cytokin cc-1 | |
DK1431391T3 (da) | RANTES-mutanter og terapeutiske anvendelser heraf | |
ATE438658T1 (de) | Neue polypeptide aus bienengift und dessen gebrauchsverfahren | |
TR200001102T2 (tr) | İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları. | |
BG103543A (en) | The use of pramipexol in the treatment of the uneasy legs syndrome | |
ATE186731T1 (de) | Anomere fluorribosylamine | |
MX9205978A (es) | Nuevas proteinas inhibidoras de trombina de garrapatas. | |
FR2710244B3 (fr) | Composition diététique à base d'acides aminés essentiels. | |
SE8802323D0 (sv) | 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
IT1225212B (it) | Procedimento e mezzi per l'impressione in rilievo di tessuti, o pelli e simili | |
Dozeman | The Life of Moses: The Yahwist as Historian in Exodus-Numbers | |
IT8722543V0 (it) | Cerotto, in particolare per l'impiego in corrispondenza di zone articolari. | |
DE3689850D1 (de) | Peptide und deren Verwendung in der Therapie. | |
IT1268425B1 (it) | Sistema, per strumenti musicali e simili, in grado di interagire con l'utente segnalandogli, mediante illuminazioni, la corretta | |
ES2127133A1 (es) | Utilizacion de derivados 2,5-dihidroxibencenosulfonicos para la fabricacion de medicamentos destinados al tratamiento y a la prevencion de la enfermedad de alzheimer. | |
IT1230707B (it) | Pirimidine 2 4 disostituite loro preparazione ed impieghi terapeutici. | |
ITRM930343A0 (it) | Proteine ricombinanti, vettori per l'espressione e loro usi. |